Matthew J Feinstein

  • 710 Citations
20042023
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2004 2020

Filter
Review article
2020

Epidemiology, pathophysiology, and prevention of heart failure in people with HIV

Sinha, A. & Feinstein, M., Jan 1 2020, (Accepted/In press) In : Progress in Cardiovascular Diseases.

Research output: Contribution to journalReview article

Epidemiology
Heart Failure
HIV
Vulnerable Populations
Cardiomyopathies
2019
4 Citations (Scopus)

Coronary Artery Disease Manifestations in HIV: What, How, and Why

Sinha, A. & Feinstein, M. J., Mar 1 2019, In : Canadian Journal of Cardiology. 35, 3, p. 270-279 10 p.

Research output: Contribution to journalReview article

Coronary Artery Disease
HIV
Inflammation
Toll-Like Receptor 2
Tobacco Use
2016
9 Citations (Scopus)

Cardiovascular Complications of HIV in Endemic Countries

Feinstein, M. J., Bogorodskaya, M., Bloomfield, G. S., Vedanthan, R., Siedner, M. J., Kwan, G. F. & Longenecker, C. T., Nov 1 2016, In : Current Cardiology Reports. 18, 11, 113.

Research output: Contribution to journalReview article

HIV
Cardiovascular Diseases
Virus Diseases
AIDS-Related Opportunistic Infections
Public Health
4 Citations (Scopus)

Monoclonal Antibodies for Lipid Management

Feinstein, M. J. & Lloyd-Jones, D. M., Jul 1 2016, In : Current atherosclerosis reports. 18, 7, 39.

Research output: Contribution to journalReview article

Monoclonal Antibodies
Lipids
LDL Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Clinical Trials
5 Citations (Scopus)

PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: Alirocumab

Dahagam, C., Goud, A., Abdelqader, A., Hendrani, A., Feinstein, M. J., Qamar, A., Joshi, P. H., Swiger, K. J., Byrne, K., Quispe, R., Jones, S. R., Blumenthal, R. S. & Martin, S. S., Mar 1 2016, In : Future Cardiology. 12, 2, p. 149-157 9 p.

Research output: Contribution to journalReview article

LDL Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Monoclonal Antibodies
Outcome Assessment (Health Care)
Diet
5 Citations (Scopus)

PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: Evolocumab

Dahagam, C., Goud, A., Abdelqader, A., Hendrani, A., Feinstein, M. J., Qamar, A., Joshi, P. H., Swiger, K. J., Byrne, K., Quispe, R., Jones, S. R., Blumenthal, R. S. & Martin, S. S., Mar 2016, In : Future Cardiology. 12, 2, p. 139-148 10 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
LDL Cholesterol
Hyperlipoproteinemia Type II
Life Style
Monoclonal Antibodies
2015
55 Citations (Scopus)

A Systematic Review of the Usefulness of Statin Therapy in HIV-Infected Patients

Feinstein, M. J., Achenbach, C. J., Stone, N. J. & Lloyd-Jones, D. M., Jun 15 2015, In : American Journal of Cardiology. 115, 12, p. 1760-1766 7 p., 21063.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
HIV
Therapeutics
Cardiovascular Diseases
Safety
2004
18 Citations (Scopus)

Emerging, noninvasive surrogate markers of atherosclerosis

Patel, S. N., Rajaram, V., Pandya, S., Fiedler, B. M., Bai, C. J., Neems, R., Feinstein, M., Goldin, M. & Feinstein, S. B., Jan 2004, In : Current atherosclerosis reports. 6, 1, p. 60-68 9 p.

Research output: Contribution to journalReview article

Atherosclerosis
Biomarkers
Ankle Brachial Index
Brachial Artery
Carotid Arteries